Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 14 studies | 25% ± 8% | |
lung | 10 studies | 27% ± 10% | |
intestine | 7 studies | 22% ± 11% | |
eye | 5 studies | 23% ± 9% | |
lymph node | 5 studies | 22% ± 4% | |
kidney | 4 studies | 22% ± 3% | |
liver | 4 studies | 27% ± 17% | |
uterus | 3 studies | 30% ± 13% | |
breast | 3 studies | 18% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 5482.74 | 226 / 226 | 100% | 118.49 | 406 / 406 |
ovary | 100% | 4436.66 | 180 / 180 | 100% | 214.80 | 430 / 430 |
skin | 100% | 8274.58 | 1809 / 1809 | 100% | 188.89 | 472 / 472 |
brain | 100% | 6173.46 | 2640 / 2642 | 100% | 186.46 | 705 / 705 |
uterus | 100% | 6097.17 | 170 / 170 | 100% | 137.23 | 458 / 459 |
esophagus | 100% | 6192.99 | 1445 / 1445 | 99% | 90.54 | 182 / 183 |
intestine | 100% | 6316.61 | 966 / 966 | 99% | 125.67 | 523 / 527 |
prostate | 100% | 5730.59 | 245 / 245 | 99% | 110.78 | 498 / 502 |
thymus | 100% | 5269.90 | 652 / 653 | 99% | 105.84 | 601 / 605 |
lung | 100% | 5422.43 | 578 / 578 | 99% | 116.40 | 1145 / 1155 |
pancreas | 100% | 2861.50 | 327 / 328 | 99% | 93.31 | 177 / 178 |
breast | 100% | 6398.30 | 459 / 459 | 99% | 136.19 | 1108 / 1118 |
stomach | 100% | 4724.51 | 359 / 359 | 99% | 110.85 | 283 / 286 |
bladder | 100% | 6009.86 | 21 / 21 | 98% | 130.51 | 495 / 504 |
kidney | 100% | 6145.10 | 89 / 89 | 98% | 60.16 | 881 / 901 |
adrenal gland | 100% | 5621.51 | 258 / 258 | 95% | 69.84 | 219 / 230 |
adipose | 100% | 5793.95 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 227.79 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 157.49 | 29 / 29 |
muscle | 100% | 5797.39 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 5741.31 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 127.94 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 145.39 | 1 / 1 |
blood vessel | 100% | 5428.13 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 98% | 4275.03 | 846 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 97% | 4055.14 | 897 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006915 | Biological process | apoptotic process |
GO_0006376 | Biological process | mRNA splice site recognition |
GO_0000381 | Biological process | regulation of alternative mRNA splicing, via spliceosome |
GO_0000380 | Biological process | alternative mRNA splicing, via spliceosome |
GO_0030054 | Cellular component | cell junction |
GO_0005654 | Cellular component | nucleoplasm |
GO_1990904 | Cellular component | ribonucleoprotein complex |
GO_0045296 | Molecular function | cadherin binding |
GO_0003677 | Molecular function | DNA binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0005515 | Molecular function | protein binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | PUF60 |
Protein name | Poly(U) binding splicing factor 60 Poly(U)-binding-splicing factor PUF60 (60 kDa poly(U)-binding-splicing factor) Fuse-binding protein-interacting repressor, isoform CRA_h (Poly(U) binding splicing factor 60) Poly(U)-binding-splicing factor PUF60 (60 kDa poly(U)-binding-splicing factor) (FUSE-binding protein-interacting repressor) (FBP-interacting repressor) (Ro-binding protein 1) (RoBP1) (Siah-binding protein 1) (Siah-BP1) |
Synonyms | FIR SIAHBP1 hCG_40718 ROBPI |
Description | FUNCTION: DNA- and RNA-binding protein, involved in several nuclear processes such as pre-mRNA splicing, apoptosis and transcription regulation. In association with FUBP1 regulates MYC transcription at the P2 promoter through the core-TFIIH basal transcription factor. Acts as a transcriptional repressor through the core-TFIIH basal transcription factor. Represses FUBP1-induced transcriptional activation but not basal transcription. Decreases ERCC3 helicase activity. Does not repress TFIIH-mediated transcription in xeroderma pigmentosum complementation group B (XPB) cells. Is also involved in pre-mRNA splicing. Promotes splicing of an intron with weak 3'-splice site and pyrimidine tract in a cooperative manner with U2AF2. Involved in apoptosis induction when overexpressed in HeLa cells. Isoform 6 failed to repress MYC transcription and inhibited FIR-induced apoptosis in colorectal cancer. Isoform 6 may contribute to tumor progression by enabling increased MYC expression and greater resistance to apoptosis in tumors than in normal cells. Modulates alternative splicing of several mRNAs. Binds to relaxed DNA of active promoter regions. Binds to the pyrimidine tract and 3'-splice site regions of pre-mRNA; binding is enhanced in presence of U2AF2. Binds to Y5 RNA in association with RO60. Binds to poly(U) RNA. . |
Accessions | A0A994J6K6 ENST00000703849.1 [Q9UHX1-3] ENST00000456095.6 [Q9UHX1-5] ENST00000531897.5 ENST00000529999.5 ENST00000349157.10 [Q9UHX1-2] ENST00000703847.1 A0A994J6L7 H0YEM1 ENST00000533162.2 ENST00000313352.11 [Q9UHX1-4] E9PMU7 Q9UHX1 ENST00000527197.5 [Q9UHX1-6] ENST00000533362.2 ENST00000532127.6 E9PQ56 E9PL19 ENST00000527744.6 ENST00000526459.6 A0A994J4J5 ENST00000703846.1 [Q9UHX1-3] ENST00000703850.1 ENST00000531951.6 [Q9UHX1-3] ENST00000703866.1 [Q9UHX1-1] ENST00000526683.6 [Q9UHX1-1] ENST00000532884.1 ENST00000453551.6 [Q9UHX1-3] E9PN18 H0YCP8 ENST00000703852.1 |